article thumbnail

BioDesign: Accelerating the Momentum of Bioconjugate Therapeutics

Fierce Pharma

Antibody-drug conjugates are a promising biopharma modality but specialized expertise is instrumental for successfully bringing drugs to the clinic. Over the last several decades, mounting interest has positioned bioconjugate therapeutics as one of the most promising biopharmaceutical modalities.

Biopharma 215
article thumbnail

ebook: A practical guide to single-use filtration in biopharma

European Pharmaceutical Review

Single-use filtration systems can help streamline processes and enhance efficiency of biopharma production. Sterile filtration: The crucial line of defence against life-threatening microorganisms, with insights into diverse membrane technologies and specialized viral clearance solutions. Interested to know more?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

For cell and gene therapy applications, you need a variety of speciality enzymes of the highest purity, specificity, and consistency. Developing best-in-class speciality enzymes. Novozymes has a long legacy of enzyme discovery and the ability to genetically engineer these speciality enzymes to be superior.

article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. Speciality pharmacies provide comprehensive medications for individuals with serious medical conditions requiring complex treatments, including cancer, cystic fibrosis, haemophilia, hepatitis, HIV, and others.

article thumbnail

Biopharma struggling to find talent with adequate digital skills

European Pharmaceutical Review

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

article thumbnail

How a specialized commercial program management team can improve your customer experience and accelerate commercialization 

Pharmaceutical Technology

For more information about how Baxter BioPharma Solutions manufacturing expertise can support your project, download the content below.  The post How a specialized commercial program management team can improve your customer experience and accelerate commercialization appeared first on Pharmaceutical Technology.

article thumbnail

Ajinomoto Adds Gene Therapy to CDMO Scope via $554M Forge Bio Buyout

MedCity News

Forge specializes in manufacturing AAV vectors used to deliver these therapies. Ajinomoto’s Forge Biologics acquisition brings contract development and manufacturing organization capabilities in gene therapy.